Nebenwirkungen · Teizeild
Teizeild 1 mg/mL concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 8
HOS-147803 · Präparat HOS-099758
• Anaphylaxis (with hypoxia and bronchospasm) was observed in one patient treated with Teizeild who was hospitalised. • Angioedema (periorbital and facial) was observed in 0.2% patients treated with Teizeild, • Peripheral and generalised oedema was reported in 1.2% of patients treated with Teizeild. • Rash was observed in 36% of patients treated with Teizeild. 0.3% of patients treated with Teizeild had a serious rash. • Urticaria was reported in 2.7% of patients treated with Teizeild. • Hypersensitivity reactions were reported in 1% of patients treated with Teizeild. Less than 0.1% of patients treated with Teizeild had a serious hypersensitivity reaction.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-08-20T11:11:01Z · SHA-256 a602de855357a77f5a78b4bee9476a1e2add62dbdd8131dbb7a097ed06bebdd8 · Passage 1b996f1703f9f9c3225eb1f81318d3771fe2f70cf579cf6d044cc1d3e48a0679 · Zeichen 5206–5925 im Abschnitt